Alnylam Pharmaceuticals Inc (ALNY) EVP, Chief Legal Officer Laurie Keating Sold $7.6 million of Shares

Author's Avatar
Jul 15, 2020
Article's Main Image

EVP, Chief Legal Officer of Alnylam Pharmaceuticals Inc (30-Year Financial, Insider Trades) Laurie Keating (insider trades) sold 47,250 shares of ALNY on 07/13/2020 at an average price of $160.67 a share. The total sale was $7.6 million.

Alnylam Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in developing novel therapeutics based on RNA interference, or RNAi. RNAi is a naturally occurring biological pathway within cells for regulating the expression of specific genes. Alnylam Pharmaceuticals Inc has a market cap of $18.02 billion; its shares were traded at around $156.91 with and P/S ratio of 60.81. GuruFocus has detected 2 severe warning signs with Alnylam Pharmaceuticals Inc. .

Directors and Officers Recent Trades:

  • EVP, Chief Legal Officer Laurie Keating sold 47,250 shares of ALNY stock on 07/13/2020 at the average price of $160.67. The price of the stock has decreased by 2.34% since.
  • COO Yvonne Greenstreet sold 46,639 shares of ALNY stock on 07/10/2020 at the average price of $161. The price of the stock has decreased by 2.54% since.
  • COO Yvonne Greenstreet sold 11,236 shares of ALNY stock on 07/09/2020 at the average price of $161. The price of the stock has decreased by 2.54% since.
  • President Barry E Greene sold 22,265 shares of ALNY stock on 07/07/2020 at the average price of $159.99. The price of the stock has decreased by 1.93% since.
  • President, R&D Akshay Vaishnaw sold 970 shares of ALNY stock on 06/22/2020 at the average price of $151.07. The price of the stock has increased by 3.87% since.

For the complete insider trading history of ALNY, click here

.